Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioGaia, a biotechnology company that develops, markets and sells probiotic products, has signed a new agreement with Interbat, an Indonesian pharmaceutical company, to sell BioGaia Probiotic drops in Indonesia under the BioGaia brand. The roll-out is expected during the first quarter of 2011.
Subscribe to our email newsletter
Most of Interbat’s business is manufacturing and sales of its own prescription and over the counter pharmaceuticals. The company is represented in 1200 of Indonesian hospitals. From a total of 900 the company’s representatives, around 700 will sell BioGaia Probiotic drops.
BioGaia Probiotic tablets are already on the market in Indonesia through the pharmaceutical company Kalbe Farma.
Peter Rothschild, president of BioGaia, said: “We are very much looking forward to the cooperation with Interbat. The company has a strong local position and regularly visits paediatricians, who are the target group for our probiotic drops.”